{"id":413506,"date":"2010-03-10T09:13:00","date_gmt":"2010-03-10T14:13:00","guid":{"rendered":"e2249889-c78b-43e3-9643-b1d7d4aa587b:405688"},"modified":"2010-03-10T09:13:00","modified_gmt":"2010-03-10T14:13:00","slug":"oil-fda-approvals-upgrades-and-downgrades-%e2%80%93-vialoux","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/413506","title":{"rendered":"Oil, FDA approvals, upgrades and downgrades \u2013 Vialoux"},"content":{"rendered":"<p>U.S. equity index futures are mixed this morning. S&amp;P 500 futures are unchanged. <\/p>\n<p>Crude oil added $0.13 per barrel after OPEC raised its forecast for crude oil demand in 2010 to 900,000 barrels per day. \u2018Tis the season for crude oil prices to move higher. <\/p>\n<p>Allergan gained 2% after the company received FDA approval to market botox for additional health care purposes. <\/p>\n<p>Chevron was downgraded Bank of America\/Merrill from Buy to Neutral.<\/p>\n<p>Pengrowth gained 1% after BMO Capital Markets upgraded the trust from Market Perform to Outperform<\/p>\n<p>Intermune rose 15% after receiving an FDA panel approval of its lung disease drug. <\/p>\n<p>Celestica was downgraded by Scotia Capital from Outperform to Sector Perform. <\/p>\n<p>Brown Foreman is slightly higher after reporting better than consensus quarterly earnings.&nbsp; <\/p>\n<p><i>Don Vialoux, chartered market technician, is the author of a free<br \/>\ndaily report on equity markets, sectors, commodities, equities and<br \/>\nExchange-Traded Funds. For more visit <a href=\"http:\/\/www.timingthemarket.ca\/techtalk\/\" >Don Vialoux&#39;s Web site<\/a><\/i><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/network.nationalpost.com\/NP\/aggbug.aspx?PostID=405688\" width=\"1\" height=\"1\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>U.S. equity index futures are mixed this morning. S&amp;P 500 futures are unchanged. Crude oil added $0.13 per barrel after OPEC raised its forecast for crude oil demand in 2010 to 900,000 barrels per day. \u2018Tis the season for crude oil prices to move higher. Allergan gained 2% after the company received FDA approval to [&hellip;]<\/p>\n","protected":false},"author":4059,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-413506","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/413506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/4059"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=413506"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/413506\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=413506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=413506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=413506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}